Method of treating the syndrome of coronary heart disease risk factors in humans
AssigneeCpd, LLC
InventorAnton H. Clemens
Life of this patent
Estimating the term…
Abstract
The invention provides an improved method of treating a human suffering from one or more conditions included within the Coronary Heart Disease Risk Factor (CHDRF) syndrome. The method includes administering, by a pharmaceutically effective mode, a drug composition having an opioidergic agent including an opiate antagonist, opiate having μ-agonist activity or combination thereof, and an insulin secretagogue.
Claims55
A method of treating a human suffering from one or more conditions included within Coronary Heart Disease Risk Factor (CHDRF) syndrome, the method comprising administering, by a pharmaceutically effective mode, a drug composition comprising:
- an opioidergic agent;
- and
- an insulin secretagogue.
A method of treating a human suffering from one or more conditions included within Coronary Heart Disease Risk Factor (CHDRF) syndrome, the method comprising administering, by a pharmaceutically effective mode, a drug composition comprising:
- an opiate antagonist;
- and
- an insulin secretagogue.
A method of treating a human suffering from one or more conditions included within the Coronary Heart Disease Risk Factor (CHDRF) syndrome, the method comprising administering, by a pharmaceutically effective mode, a drug composition comprising:
- an opiate agonist;
- and
- an insulin secretagogue.
Dependencies are inferred from the claim text.